TickerFactsScreenerDevelopers

Aprea Therapeutics, Inc. (APRE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$14.00M2018: -$15.25M2019: -$26.71M2020: -$41.80M2021: -$37.69M2022: -$25.01M2023: -$12.18M2024: -$13.56M2025: -$12.89M-$12.89M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.89M+4.9%
2024-$13.56M-11.3%
2023-$12.18M+51.3%
2022-$25.01M+33.6%
2021-$37.69M+9.8%
2020-$41.80M-56.5%
2019-$26.71M-75.1%
2018-$15.25M-8.9%
2017-$14.00M—